OPHTHALMALOGICA – Peer-reviewed journal of EURETINA

Vol 236 Issue 3, edited by Sebastian Wolf

OPHTHALMALOGICA –  Peer-reviewed journal of EURETINA
Sebastian Wolf
Published: Monday, December 5, 2016
opthalmologica   CLOT-BUSTER EFFECTIVE IN SUBRETINAL HAEMORRHAGES Vitrectomy combined with subretinal rtPA injection and gas or air tamponade can improve vision and reduce lesion size in eyes with subretinal haemorrhages (SRHs) alone and with combined subretinal and subpigment epithelial haemorrhages (SPHs). The treatment also seems to slightly improve the anatomical outcome in eyes with SPH alone, an observational study suggests. It showed that among 19 eyes with SRH and 53 eyes with combined haemorrhages, the mean best corrected visual acuity (BCVA) improved significantly following treatment. There were also significant reductions in maximal haemorrhage diameter (MHD), and central macular thickness (CMT) (p<0.05). M Waizel et al, “Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Haemorrhages”; Ophthalmologica 2016, Volume 236, Issue 3. HIGH INTRAVITREAL VEGF LEVELS PREDICT WORSE VITRECTOMY OUTCOMES Patients with proliferative diabetic retinopathy (PDR) who have higher levels of intravitreal vascular endothelial growth factor (VEGF) have a significantly worse postoperative visual acuity following vitrectomy than those with lower levels, a new study suggests. It showed that, among 136 eyes of 114 PDR patients vitrectomised between 2006 and 2008, corrected visual acuity six months after surgery was significantly worse in those with intravitreal VEGF levels 5,000 pg/mL or higher than it was in those with higher levels of the growth factor (p=0.02). Reoperations were also significantly less common among those with low VEGF levels. Y Suzuki et al, “Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy”; Ophthalmologica 2016, Volume 236, Issue 3. HYPHAEMA FOLLOWING VITRECTOMY High myopia and scleral buckling procedures combined with vitrectomy are risk factors for postoperative hyphaema following surgery for primary rhegmatogenous retinal detachment (RRD), a new study suggests. Among 1,011 consecutive eyes that underwent surgery for RRD, 32 had postoperative hyphaema. A comparison between eyes with and without the complication indicated that the likelihood of hyphaema was over three times higher among high myopes (odds ratio 3.396; p=0.003), and over 20 times higher among those who underwent a combined scleral buckling-vitrectomy procedure (OR 21.266; p<0.001), than among the patients overall. Y Kung et al, “Risk Factors for Hyphema following Surgeries for Primary Rhegmatogenous Retinal Detachment”; Ophthalmologica 2016, Volume 236, Issue 3.
Latest Articles
Nutrition and the Eye: A Recipe for Success

A look at the evidence for tasty ways of lowering risks and improving ocular health.

Read more...

New Award to Encourage Research into Sustainable Practices

Read more...

Sharing a Vision for the Future

ESCRS leaders update Trieste conference on ESCRS initiatives.

Read more...

Extending Depth of Satisfaction

The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.

Read more...

Conventional Versus Laser-Assisted Cataract Surgery

Evidence favours conventional technique in most cases.

Read more...

AI Scribing and Telephone Management

Automating note-taking and call centres could boost practice efficiency.

Read more...

AI Analysis and the Cornea

A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.

Read more...

Cooking a Feast for the Eyes

A cookbook to promote ocular health through thoughtful and traditional cuisine.

Read more...

Need to Know: Spherical Aberration

Part three of this series examines spherical aberration and its influence on higher-order aberrations.

Read more...

Generating AI’s Potential

How generative AI impacts medicine, society, and the environment.

Read more...